Setting a milestone in the healthcare industry, India is set to launch the first ever indigenously made vaccine against cervical cancer will be launched by Union Minister of state (Independent Charge) Science and Technology Jithendra Singh in New Delhi. This is the first Quadrivalent Human Papillomavirus vaccine (qHPV) developed by the Serum Institute of India and the Department of Biotechnology.
It has been proved that the indigenous vaccine is effective in 85-90 percent cases. It is expected that two doses of vaccine in 9-14 year girls will make them safe against cervical cancer. Studies state that if the girls are vaccinated properly, there will not be even a single case of cervical cancer after 30 years. Indian vaccine will help to solve the global market shortage too.
The vaccine has no side effects as there is no virus DNA or any live elements present in HPV vaccine. Though the vaccine recipient may feel fever, nausea, body pain or headache, those discomfort may vanish within a short span. However, the vaccine is not recommended for patients with contagious diseases, allergy or S L E.
The statistics on the death rate indicate that in every eight minutes in India, a woman dies of cervical cancer.